Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Colorectal Neoplasms × tucatinib × Clear all

Phase

Status

Active not recruiting 2 Withdrawn 1 Terminated 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 11 Triple Negative Breast Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 2 Multiple Myeloma 2 Meningeal Neoplasms 2 Lymphoma, Non-Hodgkin 2 Stomach Neoplasms 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Meningeal Carcinomatosis 1 Hemangiosarcoma 1 HER2-positive Breast Cancer 1 Colorectal Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1 Adenocarcinoma 1

Interventions

Bevacizumab 65 Fluorouracil 45 Cetuximab 43 Oxaliplatin 33 Leucovorin 33 pembrolizumab 32 Irinotecan 27 Folfox protocol 21 Specimen Handling 18 HMPL-013 18 Capecitabine 18 Blood Specimen Collection 16 trifluridine tipiracil drug combination 15 Magnetic Resonance Spectroscopy 13 regorafenib 12 Biopsy 12 Panitumumab 11 Cisplatin 11 Trifluridine 10 Nivolumab 10 Gemcitabine 10 Carboplatin 10 Interviews as Topic 9 IFL protocol 9 Drug Therapy 9 Colonoscopy 9 encorafenib 8 Standard of Care 8 tislelizumab 7 sintilimab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05253651 2026-03-16

MOUNTAINEER-03

Seagen Inc.

Phase 3 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡